| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.4M | +202.1% |
| Cost of Revenue | $6.4M | — |
| R&D Expense | $23.5M | +24.7% |
| SG&A Expense | $21.1M | +25.6% |
| Operating Income | -$45.7M | -29.0% |
| Pre-tax Income | -$47.2M | -32.6% |
| Income Tax | -$3.3M | -2153.1% |
| Net Income | -$43.4M | -23.8% |
| EPS (Basic) | -$1.70 | -20.6% |
| EPS (Diluted) | -$1.70 | -14.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $8.4M | +4.7% |
| Short-term Investments | $35.8M | -59.4% |
| Accounts Receivable | $81K | +23.3% |
| Current Assets | $50.1M | -49.6% |
| Total Assets | $104.4M | -13.7% |
| Current Liabilities | $18.0M | +282.1% |
| Total Liabilities | $32.0M | +258.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.7M | +85.0% |
| Capital Expenditures | $20.1M | +956.2% |
| Investing Cash Flow | $11.0M | +12.5% |
| Financing Cash Flow | -$4.9M | -119.3% |
| Free Cash Flow | -$25.8M | +35.5% |
| Stockholders' Equity |
| $73.9M |
| -34.6% |